pharmaphorum

JUNE 17, 2025

Skip to main content Tuesday 17 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Pharmaceutical Companies 89

Pharmaceutical Companies Pharmaceutical Companies FDA 89

European Pharmaceutical Review

APRIL 26, 2024

“approval [of Pyzchiva ® (biosimilar ustekinumab)] of is a crucial step towards offering European patients an additional safe and effective treatment option” Pharmaceutical company Sandoz has announced that the European Commission (EC) has granted marketing authorisation for Pyzchiva ® (biosimilar ustekinumab ).

Packaging 98

Packaging Pharmaceutical Companies Pharmaceutical Companies FDA 98

pharmaphorum

JUNE 17, 2025

billion takeover bid for Verve Therapeutics, upgrading a collaboration between the two companies that dates back to 2023. billion takeover bid for Verve Therapeutics, upgrading a collaboration between the two companies that dates back to 2023.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies FDA 59

Pharmaceutical Technology

JUNE 6, 2025

We are going to make this country the hub of biotechnology innovation,” RFK Jr said during a US Food and Drug Administration (FDA) roundtable on cell and gene therapy on 5 June. Robert Barrie June 6, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook US health secretary Robert F Kennedy Jr.

Communication 81

Communication Hospitals Insurance FDA 81

pharmaphorum

JUNE 10, 2025

Skip to main content Tuesday 10 June 2025 twitter linkedin facebook rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Pharmaceutical Companies 85

Pharmaceutical Companies Pharmaceutical Companies FDA 85

The Checkup by Singlecare

AUGUST 14, 2024

Ozempic (semaglutide) is an injectable drug approved by the Food and Drug Administration (FDA) to treat Type 2 diabetes and reduce the risk of major cardiovascular events in people with Type 2 diabetes and known heart disease. Ozempic is not approved by the FDA for weight loss. Is Ozempic approved for weight loss?

Labelling 88

Labelling FDA Insurance Insurance Coverage 88

pharmaphorum

JUNE 20, 2025

Skip to main content Friday 20 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies FDA 52

European Pharmaceutical Review

JULY 4, 2024

In the US, botanical dietary supplements can be sold without US Food and Drug Administration (FDA) approval, 1 prompting many vendors to promote the use of botanical products as dietary supplements , 2 rather than pursue a path of regulatory approval. 3 Is two too few? 3 Is two too few?

FDA 103

FDA Documentation Pharmaceutical Companies Pharmaceutical Companies 103

Pharmaceutical Technology

MAY 30, 2023

Biotechnology company BioSenic’s affiliate Medsenic has amended its licence agreement with Australia-based pharmaceutical company Phebra for the oral formulation of arsenic trioxide (OATO). The licence agreement is contingent upon Medsenic’s ability to initiate a clinical study before 31 May 2024.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies FDA 52

pharmaphorum

JUNE 23, 2025

Skip to main content Monday 23 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

59

59

pharmaphorum

JUNE 16, 2025

Skip to main content Monday 16 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies FDA 59

The Checkup by Singlecare

FEBRUARY 14, 2025

It is also commonly prescribed off-label (for non-FDA-approved use) to help with weight loss and weight management in people with obesity or who are overweight with weight-related medical conditions. So, what is compounded tirzepatide, and why is it made when there are already FDA-approved tirzepatide products available?

Compounding 52

Compounding Compounding Pharmacies Insurance Coverage FDA 52

The Checkup by Singlecare

FEBRUARY 13, 2025

It was approved by the Food and Drug Administration (FDA) in 2022 to help control blood sugar levels in adults with Type 2 diabetes , but healthcare providers often prescribe this medicine off-label (for a non-FDA-approved use) for weight loss in people with obesity (or overweight with certain medical conditions).

Compounding 52

Compounding Insurance Coverage Insurance FDA 52

The Checkup by Singlecare

FEBRUARY 13, 2025

Eli Lilly and Company, the pharmaceutical company that manufactures FDA-approved tirzepatide products, currently makes two medicines that contain tirzepatide. There are no FDA-approved generic versions of these two drugs, and there are no other FDA-approved tirzepatide products.

Compounding 52

Compounding Insurance Coverage Compounding Pharmacies FDA 52

Roots Analysis

AUGUST 1, 2024

GLP-1 receptor agonist market have captured the attention of both large and small pharmaceutical companies, for more than a decade. Some of the GLP-1, namely Trulicity®, Mounjaro®, Zepbound®, Feisumei®, Rybelsus®, Ozempic®, Wegovy® were approved for the treatment of various target indication, by the US FDA and the EMA.

Insurance Coverage 52

Insurance Coverage Insurance Packaging Pharmaceutical Companies 52

European Pharmaceutical Review

MARCH 7, 2024

Lastly, there is growing prominence and interest in radioligand therapeutics within major pharmaceutical companies, who are increasingly investing in this field, evident through recent acquisitions of Point Biopharma and RayzeBio. The construction started a year ago and the Indianapolis ATLab should produce its first dose by mid-2024.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Immunization FDA 52

The Checkup by Singlecare

APRIL 5, 2024

When the Food and Drug Administration (FDA) approved Mounjaro (tirzepatide) in 2022 to treat Type 2 diabetes, some people hailed the GIP and GLP-1 medication as the next great antidiabetic drug. Pharmaceutical companies typically only provide prescription drug samples to healthcare providers, who keep them in the office for patients to use.

Insurance 59

Insurance Compounding Pharmacies Compounding Insurance Coverage 59

The Checkup by Singlecare

OCTOBER 16, 2024

Aimovig is made by the pharmaceutical company Amgen, Inc. Ajovy is made by Teva Pharmaceuticals USA. Aimovig vs. Ajovy: Key differences Both Aimovig and Ajovy are brand-name CGRP inhibitors and are approved by the Food and Drug Administration (FDA) for use in adults for migraine prevention.

Insurance 52

Insurance Insurance Coverage Dosage Pharmaceutical Companies 52

pharmaphorum

APRIL 19, 2022

RudaCure’s leading product in development RCI001, is an ophthalmic solution for the treatment of Dry Eye Disease looking to start Phase 1 trials in South Korea and Phase 2 FDA clinical trials by 2023. Next in the pipeline, is a non-opioid treatment for chronic pain looking to complete pre-clinical studies by 2024.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication FDA 52

Pharmaceutical Technology

JANUARY 10, 2023

There are multiple drugs in the pipeline, predominantly me-too and biosimilar therapies, with a significant number developed in the emerging markets of India and China by domestic pharmaceutical companies for their own rapidly growing markets.

Labelling 52

Labelling Pharmaceutical Companies Pharmaceutical Companies Compounding 52

The Checkup by Singlecare

JUNE 10, 2024

Enbrel is also approved by the Food and Drug Administration (FDA) to treat polyarticular juvenile idiopathic arthritis (JIA) in patients ages two and older. “As Enbrel is one of several TNF inhibitors approved by the FDA. In 2024, that limit is $5,030.

Insurance 40

Insurance Insurance Coverage Pharmaceutical Companies Pharmaceutical Companies 40

ISPE

JULY 7, 2023

7 The workshop was attended by participants from industry, academia, the US FDA, and others. The organizing committee for the workshop included: Rich Chen, Executive Director, Purification & Viral Safety, Eli Lilly and Company Chris Hwang, Chief Technology Officer, Transcenta Therapeutics Inc.

FDA 52

FDA Pharmaceutical Companies Pharmaceutical Companies 52

ISPE

JULY 6, 2023

Since then, agencies have begun officially adopting the guidance, with the FDA doing so in March 2023. The EWG has now transformed to an IWG focused on developing training material throughout 2023 to complete the guidance in June 2024.

Documentation 52

Documentation FDA Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

JUNE 11, 2025

Skip to main content Wednesday 11 June 2025 twitter linkedin facebook rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views (..)

Pharmaceutical Companies 87

Pharmaceutical Companies Pharmaceutical Companies Vaccines FDA 87

The Checkup by Singlecare

MARCH 8, 2024

While nonbiologic drugs are made with chemicals and have a known structure, most biologics are complex mixtures and cannot be easily identified or characterized, according to the Food & Drug Administration (FDA). Continue reading to learn more about FDA approved Humira biosimilars, which are made by various drug companies.

Dosage 97

Dosage Pharmaceutical Companies Pharmaceutical Companies FDA 97

pharmaphorum

JUNE 6, 2025

Skip to main content Friday 6 June 2025 twitter linkedin facebook rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines FDA 52

pharmaphorum

JUNE 11, 2025

Skip to main content Wednesday 11 June 2025 twitter linkedin facebook rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views (..)

Pharmaceutical Companies 91

Pharmaceutical Companies Pharmaceutical Companies FDA 91

The Checkup by Singlecare

MARCH 10, 2025

The medication is available in both brand-name and compounded forms, although the compounded forms are not FDA approved. Compounded semaglutide is made by special compounding pharmacies rather than pharmaceutical companies. Ozempic, Wegovy, and Rybelsus are the only FDA-approved drugs that contain semaglutide.

Compounding 52

Compounding Insurance Insurance Coverage FDA 52

The Checkup by Singlecare

FEBRUARY 13, 2025

It is approved by the Food and Drug Administration (FDA) for weight loss and long-term weight management in adults and adolescents 12 years and older with obesity , as well as adults who are overweight and have at least one weight-related health condition, such as high cholesterol or Type 2 diabetes. What is compounded semaglutide?

Compounding 52

Compounding Compounding Pharmacies Insurance Coverage Insurance 52

European Pharmaceutical Review

APRIL 10, 2024

The recent FDA approvals of two microbiome products in the US, in November 2022 and April 2023, 1-2 represent a significant milestone, maturing the industry and paving the way for advancement and regulatory clearance of additional microbiome products in broader indications. Internet] Pharmaceutical Technology. cited 2024Feb].

Immunization 95

Immunization Chemotherapy FDA Pharmaceutical Companies 95

The Checkup by Singlecare

FEBRUARY 10, 2025

Food and Drug Administration ( FDA ) in 2014 for Type 2 diabetes. Since then, its FDA -approved uses have expanded, now including kidney disease, heart failure , and Type 2 diabetes. The pharmaceutical company Prasco currently markets a generic version of Farxiga. Is there a generic for Farxiga ?

Dosage 52

Dosage Labelling Hospitals FDA 52

The Checkup by Singlecare

JULY 31, 2024

Entresto is made by the pharmaceutical company Novartis and was approved by the Food and Drug Administration (FDA) in 2015. Entresto (sacubitril/valsartan) is a medicine that is classified as an angiotensin receptor neprilysin inhibitor (ARNI).

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Hospitals FDA 52

The Checkup by Singlecare

SEPTEMBER 10, 2024

It is approved by the Food and Drug Administration (FDA) to treat plaque psoriasis , psoriatic arthritis , Crohn’s disease , and ulcerative colitis. According to the FDA , biological products are complex medicines made from living cells, like those from plants or animals. Wezlana (ustekinumab-auub) was FDA approved on Oct.

FDA 52

FDA Vaccines Specialty Pharmacies Pharmaceutical Companies 52

PharmaShots

MARCH 29, 2023

Shots: Drug patent expiry is when a patent granted to a pharmaceutical company for a particular drug expires, allowing other companies to produce and sell generic versions Like every other utility patent, pharmaceuticals also get market exclusivity of 20 years. The exact mechanism of action is uncertain.

FDA 49

FDA Chemotherapy Immunization Pharmaceutical Companies 49

STAT

JULY 6, 2023

On one side is the Pharmaceutical Care Management Association, the trade association representing pharmacy benefit managers, which argues that pharmaceutical companies are responsible for high drug prices. The company hopes to launch the product in the U.S. in 2024.

Vaccines 88

Vaccines Pharmaceutical Companies Pharmaceutical Companies FDA 88

pharmaphorum

JUNE 6, 2025

Skip to main content Friday 6 June 2025 twitter linkedin facebook rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies FDA Vaccines 59

The Checkup by Singlecare

JUNE 6, 2024

Farxiga (dapagliflozin) is a brand-name prescription medication that has been approved by the Food & Drug Administration (FDA) for several indications. This law enables Medicare to negotiate directly with pharmaceutical companies, which should ultimately result in lower prescription drug costs for consumers.

Insurance 52

Insurance Hospitals Pharmaceutical Companies Pharmaceutical Companies 52